3rd Circ. Preview: Sept. Features Biosimilars, Gambling Cases

The Third Circuit's September argument lineup is packed with cases centering on the biosimilars segment of the pharmaceutical industry and gambling companies embroiled in disputes originating from New Jersey....

Already a subscriber? Click here to view full article